ADVERTISEMENT

Favipiravir

Covid: SC junks PIL on use of Remdesivir, Favipiravir

A bench of Chief Justice of India D Y Chandrachud and Justices P S Narasimha and J B Pardiwala said these issues cannot be examined by the court

10 April 2023, 08:53 IST

SC dismisses PIL on efficacy of Remdesivir and Favipiravir for Covid-19 treatment

SC dismisses PIL on efficacy of Remdesivir and Favipiravir for Covid-19 treatment

Covid: SC junks PIL on use of Remdesivir, Favipiravir

10 April 2023, 08:53 IST

Covid-19 drug Favipiravir safe, effective: Glenmark

Favipiravir was used to treat patients with moderate to mild Covid-19

15 September 2021, 09:04 IST

Covid-19 drug Favipiravir safe, effective: Glenmark

Covid-19 drug Favipiravir safe, effective: Glenmark

Covid-19 drug Favipiravir safe, effective: Glenmark

15 September 2021, 09:04 IST

Bal Pharma launches Favipiravir at Rs 85/tablet

Favipiravir is being used for patients with mild to moderate Covid-19 infection

24 May 2021, 16:49 IST

Bal Pharma launches antiviral drug Favipiravir at Rs 85/tablet

Bal Pharma launches antiviral drug Favipiravir at Rs 85/tablet

Bal Pharma launches Favipiravir at Rs 85/tablet

24 May 2021, 16:49 IST

Covid: Bharat Parenterals gets DCGI nod for favipiravir

Favipiravir, an antiviral drug, was approved in Japan in 2014 for the treatment of novel or re-emerging influenza virus infections

22 May 2021, 15:46 IST

Bharat Parenterals gets DCGI nod for favipiravir oral suspension for Covid-19 patients

Bharat Parenterals gets DCGI nod for favipiravir oral suspension for Covid-19 patients

Covid: Bharat Parenterals gets DCGI nod for favipiravir

22 May 2021, 15:46 IST

Favipiravir helps mild-to-moderate Covid cases: Study

Patients of confirmed Covid-19 with moderate symptoms were discharged from hospital earlier than those patients that did not receive Favipiravir

23 November 2020, 13:21 IST

Favipiravir leads to 'significant improvement' in mild-to-moderate Covid-19 cases: Study

Favipiravir leads to 'significant improvement' in mild-to-moderate Covid-19 cases: Study

Favipiravir helps mild-to-moderate Covid cases: Study

23 November 2020, 13:21 IST

Fujifilm applies for approval of Avigan as Covid drug

16 October 2020, 04:33 IST

Fujifilm applies for approval of Avigan as Covid-19 treatment in Japan

Fujifilm applies for approval of Avigan as Covid-19 treatment in Japan

Fujifilm applies for approval of Avigan as Covid drug

16 October 2020, 04:33 IST

Russia to give 17 more nations with Covid drug Avifavir

24 September 2020, 11:39 IST

Russia to supply 17 more countries with Covid-19 drug Avifavir

Russia to supply 17 more countries with Covid-19 drug Avifavir

Russia to give 17 more nations with Covid drug Avifavir

24 September 2020, 11:39 IST

Avigan maker to seek virus treatment approval

23 September 2020, 09:28 IST

Avigan maker to seek coronavirus treatment approval after trials

Avigan maker to seek coronavirus treatment approval after trials

Avigan maker to seek virus treatment approval

23 September 2020, 09:28 IST

Centre approved Remdesivir, Faviparivir for Covid: SC

16 September 2020, 11:14 IST

Centre approved Remdesivir, Faviparivir to treat Covid-19 patients, says SC

Centre approved Remdesivir, Faviparivir to treat Covid-19 patients, says SC

Centre approved Remdesivir, Faviparivir for Covid: SC

16 September 2020, 11:14 IST

Favipiravir tablet, Remdesivir now available in Odisha

12 September 2020, 16:36 IST

Favipiravir tablet, Remdesivir now available in Odisha markets

Favipiravir tablet, Remdesivir now available in Odisha markets

Favipiravir tablet, Remdesivir now available in Odisha

12 September 2020, 16:36 IST